The analysis examined data collated from commercial health insurance claims coupled with demographic information sourced from the Health Care Cost Institute, the American Community Survey, and March of Dimes. An aggregate of 18,893 stillbirth cases were identified among the pregnancies studied between 2016 and 2022. This extensive dataset enabled researchers to scrutinize the interplay between stillbirth incidence and a range of clinical, fetal, obstetric, and socioeconomic factors, providing an unprecedented granularity in risk assessment unmatched in prior studies.

Contrary to earlier understanding, the researchers determined that more than one in every 150 births in the United States culminate in stillbirth, a rate substantially exceeding the approximately one in 175 figure propagated by the Centers for Disease Control and Prevention (CDC). Alarmingly, in economically disadvantaged regions, the incidence rises sharply to one in 112 births. Moreover, geographic areas with higher proportions of Black families showed a stillbirth occurrence of one per 95 births, highlighting persistent racial disparities exacerbated by social determinants of health.

In assessing clinical factors, the study found compelling evidence that while a majority of stillbirths — roughly 72.3% — were associated with at least one identifiable clinical risk factor, a significant minority occurred without any diagnosed risk prior to delivery. This absence of known risk markers escalates with gestational age, with nearly 41% of stillbirths at 40 weeks or beyond lacking recognizable clinical indicators. These results present a considerable challenge for current prediction and prevention paradigms, which often rely heavily on early risk identification.

The array of clinical risk factors scrutinized includes chronic hypertension, pregnancy-related hypertension, gestational and pre-pregnancy diabetes, obesity, and substance use. Fetal factors such as growth restriction, decreased fetal movement, and congenital anomalies were also accounted for, alongside obstetric history elements including previous adverse pregnancy outcomes and abnormal amniotic fluid levels. These complexities illustrate the multifactorial nature of stillbirth etiology and suggest the need for integrative approaches that transcend conventional clinical surveillance.

Surprisingly, area-level access to obstetric care and rurality were not strongly correlated with stillbirth rates in this analysis. Instead, socioeconomic parameters such as income levels and racial demographics played a more decisive role, pointing to the influence of structural inequities and social determinants in perinatal outcomes. These insights demand a reevaluation of healthcare delivery models, advocating for targeted interventions tailored to mitigate disparities rooted in socioeconomic disadvantage.

The implications of these findings resonate deeply within the obstetric and public health communities, generating a call to action around enhancing stillbirth risk prediction methodologies. Current tools may inadequately capture the nuances of late-term stillbirth risks, particularly when no overt clinical warnings exist. Innovative screening strategies, perhaps incorporating advanced biomarker discovery and real-time monitoring technologies, could offer breakthroughs in identifying vulnerable pregnancies closer to term.

Jessica Cohen, co-senior author and professor of health economics, emphasizes the urgent gap in research and clinical practice addressing stillbirths. The burden is enormous—approximately 21,000 families are affected annually in the United States alone. Nearly half of stillbirths occurring after 37 weeks gestation are deemed preventable, yet lack of robust predictive capacity hinders effective intervention and resource allocation. Cohen advocates for amplified research endeavors that marry epidemiological data with molecular and physiological insights to revolutionize prevention.

Mark Clapp, co-senior author and maternal-fetal medicine specialist at Massachusetts General Hospital, stresses that despite growing momentum in stillbirth prevention, U.S. rates remain dramatically elevated compared to peer nations. He underscores the necessity of policy reforms and practice innovations informed by this study’s data, aiming to reduce the emotional and societal toll suffered by affected families. Clapp’s perspective reflects a broader commitment within academic medicine to confront persistent disparities head-on.

This investigation also spotlights an urgent need for further inquiry into the mechanisms behind socioeconomic disparities driving differential stillbirth rates. It remains unresolved whether these disparities stem principally from social determinants such as housing instability and food insecurity, health system inequities including insurance coverage and provider access, or intrinsic clinical risk distributions. Future research is tasked with disentangling these complex drivers to better inform multifaceted interventions.

Another notable aspect is the heightened risk associated with specific pregnancy conditions observed in the dataset. Low amniotic fluid volumes, fetal anomalies, and chronic hypertension emerged as the strongest predictors of stillbirth, suggesting these conditions should command heightened vigilance in clinical management protocols. The optimization of monitoring and timely intervention in such high-risk pregnancies could constitute pivotal steps toward mitigating stillbirth incidence.

Overall, this seminal study represents one of the most data-rich explorations of stillbirth burden in the United States to date. Its findings hold transformative potential for obstetric care standards, health policy formulation, and scientific exploration. By illuminating both the magnitude and complexity of stillbirths, the research invites a multidisciplinary coalition of experts—from epidemiologists to clinicians and policymakers—to join forces in designing and implementing comprehensive prevention frameworks that address clinical, social, and systemic determinants.

In conclusion, the enhanced stillbirth rates unveiled by this investigation serve as both a wake-up call and an opportunity. The compelling evidence linking disparities to socioeconomic factors and the prevalence of risk-free yet fatal outcomes demand innovative approaches to prediction, prevention, and equity restoration in prenatal care. As researchers further decode the underpinnings of stillbirth, the ultimate goal remains clear: to ensure every pregnancy results in a healthy birth, and no family endures the profound loss stillbirth inflicts.

Subject of Research:
Not applicable

Article Title:
Stillbirths in the United States

News Publication Date:
October 27, 2025

Web References:
http://dx.doi.org/10.1001/jama.2025.17392

Keywords:
Pregnancy complications, Obstetrics, Childbirth, Pregnancy, Gestational age

For decades, scientists have known that exposure to PM2.5 – particulate matter smaller than 2.5 micrometers in diameter – is linked to a variety of respiratory ailments, including asthma attacks that require hospitalization. However, PM2.5 is not a uniform entity; it’s a heterogeneous mixture of metals, organic compounds, and other chemical constituents. Prior research has largely focused on the impact of total PM2.5 mass or individual pollutants in isolation, leaving a crucial gap in understanding which specific components within PM2.5 wield the most influence over asthma outcomes.

To address this challenge, the Harvard team, led by environmental epidemiologist Joel Schwartz, employed an innovative methodological approach that bridges the gap between isolated pollutants and overall particulate matter exposure. They deployed advanced machine learning algorithms to dissect the intricate composition of PM2.5, identifying a comprehensive panel of compounds including bromine, calcium, copper, elemental carbon, iron, potassium, ammonium, nickel, nitrate, organic carbon, lead, silicon, sulfate, vanadium, and zinc. This enabled the researchers to estimate annual exposure levels of each compound at the granular scale of U.S. zip codes, a level of detail rarely achieved in environmental health studies.

In parallel, the research team leveraged expansive state inpatient databases curated by the Healthcare Cost and Utilization Project, compiling an exhaustive dataset encompassing 469,005 asthma hospitalizations from 11 states over a 14-year period, spanning 2002 to 2016. By integrating this epidemiological data with the exposure assessments, the investigators were uniquely positioned to unravel how long-term exposure to distinct PM2.5 compounds correlates with severe asthma exacerbations necessitating hospital care.

Central to their statistical analysis was a technique known as weighted quantile sum (WQS) regression. This method allows for the simultaneous evaluation of multiple correlated exposures—in this case, the chemical constituents of PM2.5—while determining the relative weight or contribution of each to the health outcome measured. Taking into consideration confounding variables such as outdoor temperature and socioeconomic status, the model revealed that incremental increases in the pollutant mixture corresponded with sizable increases in asthma hospitalizations: 10.6% among children and 8% among adults aged 19 to 64 for each decile rise in exposure.

Strikingly, the six compounds that emerged as the dominant drivers in this association were nickel, vanadium, sulfate, nitrate, bromine, and ammonium. These substances, often overlooked in broader pollution metrics, appear to disproportionately exacerbate the burden of asthma across diverse populations. The prominence of metals like nickel and vanadium is particularly noteworthy, as these are known byproducts of fuel oil combustion—a common energy source in urban infrastructures, including heating oil and heavy residual oils.

Sulfate particles, on the other hand, predominantly originate from coal combustion, which remains a major energy source in certain regions despite ongoing transitions toward cleaner fuel alternatives. The researchers emphasize that existing technological interventions, such as scrubbers on coal-fired power plants and the removal of metal contaminants from fuel oils, could effectively reduce emissions of these harmful compounds, potentially leading to tangible decreases in asthma hospitalizations.

Joel Schwartz highlighted the public health implications of these findings, stating, “We know how to control these sources if regulatory frameworks prioritize them. Targeting these specific pollutants could transform asthma management at the population level and ease the strain on healthcare systems.” This targeted approach contrasts with more generalized air quality regulations that often lack specificity regarding particulate composition.

Notably, the study also underscores the limitations of current knowledge regarding short-term exposure to PM2.5 compounds and their immediate impacts on asthma exacerbations. The authors advocate for future research to delve into acute exposure dynamics to inform timely public health interventions, such as air quality alerts tailored to the most harmful PM2.5 components.

Furthermore, the study exemplifies how integrating machine learning with large-scale epidemiological data can refine our understanding of complex environmental exposures. By dissecting the PM2.5 mixture into its chemical constituents, researchers have unlocked new avenues for precision environmental health policies that move beyond traditional pollutant metrics.

Supporting authors from Harvard T.H. Chan included Bryan Vu, Xinye Qiu, Yijing Feng, and Yaguang Wei, reflecting a collaborative effort that combined expertise in environmental science, data analytics, and respiratory health.

This research was funded by prominent agencies including the National Institutes of Environmental Health Sciences and the National Center for Advancing Translational Sciences, underscoring the significance of such interdisciplinary studies in addressing pressing public health challenges.

The detailed findings, titled “Association of Annual Exposure to Air Pollution Mixture on Asthma Hospitalizations in the United States,” promise to recalibrate environmental health priorities. By identifying the critical pollutants within fine particulate matter most responsible for asthma hospitalizations, this study equips policymakers with actionable intelligence to craft targeted interventions that could substantially improve respiratory health outcomes nationwide.

As the global community grapples with persistent air pollution and escalating respiratory disease burdens, these insights provide a clarion call for focused regulatory efforts targeting the most pernicious components of PM2.5, reinforcing the vital intersections between environmental science, public health, and policy.

Article Title: Association of Annual Exposure to Air Pollution Mixture on Asthma Hospitalizations in the United States
News Publication Date: August 29, 2025
Web References: http://dx.doi.org/10.1164/rccm.202409-1853OC
References: Vu, B.N., Amini, H., Qiu, X., Feng, Y., Wei, Y., Schwartz, J. (2025). Association of Annual Exposure to Air Pollution Mixture on Asthma Hospitalizations in the United States. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.202409-1853OC
Keywords: Air pollution, Asthma, Fine particulate matter, PM2.5, Nickel, Vanadium, Sulfate, Respiratory health, Environmental epidemiology, Machine learning, Public health policy

The investigators harnessed 2023 data from state regulatory agencies spanning 18 states that have legalized adult-use recreational cannabis sales between 2012 and 2022. These states encompass a diverse range of geographical regions, including Alaska, California, Colorado, Illinois, and Washington, among others. The researchers methodically geocoded the addresses of 5,586 licensed cannabis retailers and employed rigorous statistical modeling—specifically multilevel logistic and negative binomial Poisson regression techniques—to explore associations between neighborhood socioeconomic deprivation indices and the spatial distribution of cannabis retail availability.

Lead author Lindsay L. Kephart, PhD, MPH, pointed out that cannabis retailers are present in only about 10 percent of all census tracts within legalized states but tend to cluster prominently in the most socioeconomically vulnerable communities. “Our data demonstrate that neighborhoods characterized by high concentrations of low-income Black residents possessed 2.53 times more cannabis retailers compared to affluent, predominantly White neighborhoods,” explained Dr. Kephart. Similarly, tracts with substantial populations of low-income Hispanic residents had 2.67 times the retailer presence, vividly illustrating entrenched disparities in access and exposure.

The study situates the new data within a well-established body of literature documenting the legacy of inequitable retail environments for substances like tobacco and alcohol. Historically, tobacco and alcohol outlets have been disproportionately numerous in lower-income and minority neighborhoods, perpetuating cycles of health inequity. The emergence of legal recreational cannabis retail has, in effect, replicated and potentially amplified these patterns, raising concerns about the cumulative public health burden on communities already facing systemic disadvantages.

Delving deeper into causal pathways, Dr. Kephart highlighted the role of structural mechanisms such as historical zoning policies and Not-In-My-Backyard (NIMBY) attitudes that spatially segregate certain types of commercial activity. She elaborated, “While often not an explicit intention, such patterns funnel cannabis retailers toward marginalized neighborhoods, reinforcing existing inequities in substance exposure and economic opportunity.” This spatial patterning is a legacy of policy frameworks that disadvantage low-income and minority communities by relegating potentially ‘undesirable’ businesses to their vicinity.

Intriguingly, the study’s sensitivity analyses distinguished the effects of race and socioeconomic status. While racial disadvantage alone did not significantly predict cannabis outlet availability, the interplay of race with low-income status appeared pivotal. Neighborhoods where racial minorities and low-income residents overlap are most vulnerable to concentrated cannabis retail presence. This nuanced finding underscores the multifactorial nature of social determinants influencing retail landscapes and suggests that purely race-based interventions might miss crucial economic dimensions.

Cannabis use itself remains pervasive, with nearly 19% of Americans aged 12 or older reporting consumption in the past year. As of late 2024, 24 states have legalized recreational cannabis, pointing to a

For decades, malaria control has heavily relied on insecticide-treated bed nets, which function primarily by killing mosquitoes that come into contact with them. However, the alarming rise of insecticide resistance among Anopheles mosquito populations—the main vectors responsible for Plasmodium parasite transmission—has rendered these bed nets progressively less effective. This impasse has generated an urgent need for alternative strategies that disrupt transmission without exerting selective pressure on mosquito populations. The newly uncovered chemical combination promises to fulfill this need by targeting the parasite’s biology rather than killing the mosquito itself.

The research team embarked on a pioneering large-scale screen involving 81 antiparasitic compounds to determine their efficacy against Plasmodium falciparum—the deadliest malaria parasite responsible for over 90% of global malaria cases. Uniquely, the compounds were applied directly onto Anopheles gambiae mosquitoes to assess whether they could impair parasite development within the mosquito vector. This in vivo screening method is unprecedented in its scope and methodology, providing direct insights into the interaction between antimalarial agents and parasite development stages within the mosquito host.

Out of the extensive panel scrutinized, 22 compounds demonstrated significant impairment of parasite development. From this subset, researchers isolated two compounds exhibiting remarkable potency. These molecules exert their parasiticidal effect by inhibiting distinct enzymatic sites within the parasite’s mitochondrial electron transport chain—a critical metabolic pathway responsible for energy production. By targeting multiple sites, the combination not only amplifies the antiparasitic effect but also reduces the likelihood of resistance development in the parasite population.

To translate this biochemical discovery into viable malaria control technology, the two compounds were incorporated into prototype bed nets designed to mimic real-world usage conditions. Astonishingly, even at very low concentrations, these functionalized nets eradicated 100% of Plasmodium parasites held within the mosquitoes. Further testing confirmed the durability of the compounds’ activity, maintaining full potency for at least one year and continuing to suppress parasite viability when mosquitoes were exposed up to four days prior to infection. This temporal prophylaxis effectively minimizes the window for mosquito infectivity, substantially diminishing potential for malaria transmission.

Crucially, the compounds’ mechanism of action does not involve killing the mosquito, thereby eliminating the evolutionary pressure that typically fosters insecticide resistance. By preserving mosquito survival, this approach aligns vector control with ecological balance and sustainability principles. Lead author Alexandra Probst, a doctoral candidate involved in the research, highlights the relevance of integrating cost-effective chemistry; collaborators at Oregon Health and Science University successfully synthesized these compounds inexpensively, setting the stage for scalable implementation without imposing significant financial burdens.

Flaminia Catteruccia, a senior investigator and co-corresponding author, underscores the transformative potential of this discovery within malaria control. She emphasizes how addressing the parasite within the mosquito vector rather than targeting the mosquito itself represents a novel and promising direction—one that could revitalize malaria prevention amid stagnating progress in recent years. Given malaria’s staggering impact—263 million reported cases and nearly 600,000 deaths in 2023 alone—such innovations are critical to reversing the disease’s global toll.

The methodology employed in this research illuminates unexplored druggable targets during the mosquito-stage of the parasite’s life cycle, marking a departure from traditional antimalarials primarily focused on the human blood stage. By expanding the scope of antimalarial intervention to vector stages, the study positions itself at the forefront of vector-borne disease management research. This multidimensional targeting could pave the way for integrated approaches that combine human and vector treatment strategies for higher efficacy.

Furthermore, the study’s success rests heavily on interdisciplinary collaboration. Contributions spanned molecular parasitology, chemical synthesis, vector biology, and public health, highlighting the necessity of cross-sector partnerships in addressing complex infectious disease challenges. Funding support from the National Institutes of Health, Open Philanthropy, and several foundations underscores the high priority accorded to such efforts within global health agendas.

Looking forward, the translation of these findings into commercial antimalarial bed nets will require concerted development and regulatory efforts. Nonetheless, by circumventing the pitfalls of insecticide resistance and maintaining cost competitiveness, this advancement holds the promise of ushering in a new generation of vector control tools with the potential to substantially reduce malaria transmission worldwide. Given the sustained activity of the compounds and the ability to preempt infection in mosquitoes, deployment could radically shift the epidemiological landscape—saving lives and improving health equity in malaria-endemic regions.

In an era where malaria control has stagnated due to resistance challenges and the limits of current technologies, this research offers a beacon of hope. By simultaneously leveraging advances in chemistry, vector biology, and parasitology, the Harvard-led team has charted a course toward innovative, sustainable, and highly effective malaria prevention. This strategy not only strengthens the fight against one of humanity’s oldest scourges but exemplifies how cutting-edge science can yield practical, life-saving solutions.

Subject of Research: Animals

Article Title: In vivo screen of Plasmodium targets for mosquito-based malaria control

News Publication Date: May 21, 2025

Web References:
http://dx.doi.org/10.1038/s41586-025-09039-2

References:
Probst, A. S., Paton, D. G., Appetecchia, F., Bopp, S., Adams, K. L., Rinvee, T. A., et al. (2025). In vivo screen of Plasmodium targets for mosquito-based malaria control. Nature. doi:10.1038/s41586-025-09039-2

Keywords: Malaria, Plasmodium infections, Mosquitos, Drug resistance, Insecticide resistance, Insecticides

The findings stem from an innovative application of transposon mutagenesis, a potent genetic technique that allows researchers to systematically disrupt specific genes. This method enabled the scientists to unveil a comprehensive catalog of essential genes within P. knowlesi, thus providing new insights into how this pathogen thrives and evades treatment. Through their rigorous experimentation, they were able to identify those genetic elements critical for the parasite’s lifecycle in human red blood cells—a crucial phase that underpins malaria pathology.

This extensive genetic mapping is not merely academic. It holds vital implications for public health and medical practice, particularly in combatting the mounting challenge posed by drug-resistant strains of Plasmodium. With the threat of malaria claiming nearly 608,000 lives worldwide each year, researchers are acutely aware that addressing drug resistance is paramount. The newly identified genetic targets that contribute to this resistance could inform the development of novel therapeutic strategies, essentially enhancing our arsenal against the evolving parasite.

Prominent co-corresponding author Manoj Duraisingh emphasized the urgent need for effective interventions, stating that the emerging resistance to current antimalarial medications poses an escalating threat. The genetic map serves not only as a resource for infectious disease researchers but also lays the groundwork for future explorations into the biology of malaria parasites, thereby driving the search for innovative treatments.

A significant aspect of this research lies in the evolutionary relationship between various Plasmodium species. The findings from P. knowlesi could inadvertently provide critical insights into other malaria-causing organisms, particularly Plasmodium vivax. Despite being less studied due to its recalcitrance to laboratory culture methods, understanding the genetic framework revealed in P. knowlesi could heighten efforts aimed at the elimination of P. vivax and other related species.

The sheer volume of essential genes cataloged in this study outstrips any previous mappings from other Plasmodium species. Researchers underscore the importance of this extensive dataset, as it not only reveals the genetic necessities for the parasite’s growth but also provides a roadmap for the functional analysis necessary for highlighting significant resistance mechanisms. Each identified gene offers potential targets for drug developers who are relentlessly working to devise next-generation antimalarials.

Moving forward, this comprehensive genetic mapping will enable scientists to develop strategies to monitor and contain the emergence of drug-resistant strains. Such strategies will be critical in developing new public health frameworks to tackle malaria, particularly in regions where P. knowlesi infection is on the rise. Given its zoonotic nature, the bridge between animal reservoirs and human illness is crucial for formulating effective epidemiologic interventions.

Furthermore, the multidisciplinary team of researchers involved in this study included a range of specialists, each contributing unique insights that culminated in this expansive mapping project. The collaborative spirit exhibited highlights the importance of diverse expertise in addressing complex biological questions. Through their rigorous examination and the synthesis of various scientific approaches, the research promotes integrated methodologies that could become a model for future studies in infectious disease contexts.

As this research progresses toward publication later in the year, the hype surrounding the potential applicability of these findings builds significantly. Significantly, it not only contributes to the scientific community’s understanding of P. knowlesi, but also promises to fuel ongoing discussion about malaria’s pervasive burden on global health—a challenge that demands urgent action and novel solutions.

In summary, the extensive genetic profiling of P. knowlesi marks a critical milestone in malaria research. By establishing direct connections between specific genes and their roles in both drug resistance and parasite survival, researchers have taken definitive strides toward tailoring targeted interventions. Truly, the impact of this work could resonate for years to come, catalyzing further innovations that upscale the battle against malaria.

Through this research, a clearer picture of the essential genomic elements guiding P. knowlesi biology emerges, laying a foundation for future breakthroughs in malaria treatments. Scientists posit that tailoring future research to explore these genetic avenues could very well lead to the generation of new compounds capable of outsmarting this evolving parasite, ultimately changing the trajectory of malaria therapy.

Rather than being just a matter of scientific curiosity, this study hands researchers a vital tool in their arsenal as they combat one of the deadliest infectious diseases in the world. As both a resource for current research and a cornerstone for future investigations, this genetic map heralds a new era in our understanding and treatment of malaria.

Subject of Research:
Plasmodium knowlesi genetics

Article Title:
The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility

News Publication Date:
6-Feb-2025

Web References:
Harvard T.H. Chan School of Public Health

References:
Elsworth, B., Ye, S., Dass, S., Tennessen, J. A., Sultana, Q., Thommen, B. T., Paul, A. S., Kanjee, U., Grüring, C., Ferreira, M. U., Gubbels, M.-J., Zarringhalam, K., Duraisingh, M. T. (2025). The essential genome of Plasmodium knowlesi reveals determinants of antimalarial susceptibility. Science. doi: 10.1126/science.adq6241

Image Credits:
Not provided